SO inhibitors, or sulfite oxidase inhibitors, represent a class of compounds that interact with the enzymatic activity of sulfite oxidase (SO), a critical enzyme involved in the oxidative metabolism of sulfur-containing compounds. Sulfite oxidase plays a fundamental role in the final step of the oxidation of sulfite to sulfate, a process essential in the catabolism of sulfur amino acids such as methionine and cysteine. SO inhibitors typically function by disrupting the molybdenum cofactor at the enzyme's active site, which is necessary for its catalytic action. This interference can result from direct interaction with the molybdenum center or via binding to other sites that alter the enzyme's structural conformation, thereby impeding its ability to catalyze the oxidation of sulfites. The structure-activity relationship (SAR) of SO inhibitors is generally characterized by the presence of functional groups that have an affinity for either the molybdenum cofactor or the surrounding amino acid residues involved in sulfite oxidation.
The inhibition of sulfite oxidase by chemical compounds can lead to an accumulation of sulfite, which can have a range of biochemical consequences depending on the extent of the inhibition. Studies on SO inhibitors focus on understanding their chemical mechanisms of action, which are primarily determined through spectroscopic techniques, including electron paramagnetic resonance (EPR) and UV-Visible absorption spectroscopy, as well as kinetic assays that quantify the rate of sulfite oxidation under inhibited conditions. Insights from these studies can reveal how the inhibitors affect not only the SO enzyme but also related metabolic pathways involving sulfur-containing compounds. Research into these inhibitors also helps to elucidate the fundamental role of sulfite oxidase in redox biology, as the enzyme is a key player in maintaining sulfur homeostasis within the cell. Inhibition of this enzyme provides a chemical model to study the downstream effects of sulfur dysregulation, offering a window into broader metabolic processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SKI II | 312636-16-1 | sc-204286 sc-204286A | 10 mg 50 mg | $96.00 $400.00 | 3 | |
Directly inhibits sphingosine kinases 1 and 2 (SK1/2), enzymes critical for sphingosine-1-phosphate (S1P) synthesis, thereby reducing S1P's role in cell survival and proliferation signaling. | ||||||